New York, New York (PRWEB) June 02, 2013
Court documents indicate that more than 1,500 Actos lawsuit claims alleging bladder cancer are now pending in a federal litigation underway in the U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports.

According to court records, an update on the number of Actos filings in the federal litigation was presented at a May 23rd status conference, which also addressed troubles associated to the status of discovery and the scheduling of bellwether trials in the litigation. Lawsuits filed in this proceeding allege the possible for long-term use of Actos, a type two diabetes drug manufactured by Takeda Pharmaceuticals, to trigger or worsen bladder cancer. (In re: Actos Solution Liability Litigation, MDL No. 2299)

As we continue to receive inquiries about prospective Actos lawsuits from individuals who allege extended-term use of the drug triggered their bladder cancer, we are pleased to see this litigation moving forward, says Bernstein Liebhard LLP, nationwide law firm representing the victims of defective drugs and health-related devices. The Firm is at the moment offering free Actos bladder cancer lawsuit evaluations to individuals who developed bladder cancer right after utilizing the medication for an extended period of time.

Actos Bladder Cancer Lawsuit Allegations

The federal multidistrict litigation for Actos bladder cancer lawsuits was produced in the U.S. District Court, Western District of Louisiana in December 2011, after the U.S. Meals and Drug Administration issued an alert warning the public that long-term use of the medication might increase a individuals threat for establishing bladder cancer.* There are now 1,500 instances pending in in the Western District of Louisiana, exactly where the proceeding continues to move forward. According to court documents, the next status conference in the litigation has been scheduled for June 20, 2013. Court records further indicate the first bellwether trials for the Actos bladder cancer litigation have been scheduled as effectively, with the initial trial is slated to begin on January 27, 2014, with the second to adhere to on April 14, 2014.

In addition to the federal litigation, Bloomberg.com reported on May 1st that claims filed more than the medication employed to manage blood-sugar levels in type 2 diabetes sufferers are pending in state litigations in Illinois and California.**

Individuals who took Actos and developed bladder cancer following lengthy-term use of the drug may possibly be eligible to seek compensation for medical bills, lost wages, pain and suffering and other damages. Understand more about how to file an Actos lawsuit by going to Bernstein Liebhard LLPs web site or by calling a single of the Firms Actos lawyers at 800-511-5092.

*FDA, June 15, 2011 fda.gov/drugs/drugsafety/ucm259150.htm
**bloomberg.com/news/2013-05-01/takeda-gets-six-five-million-diabetes-drug-verdict-thrown-out.html

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, which includes these who have been harmed by harmful drugs, defective health-related devices and customer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the nation, for the previous ten consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

Attorney Advertising.